This metabolite contains a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 somewhere around fifty% of your parent drug. Plasma concentrations of this metabolite are approximately forty% of All those noticed for sildenafil, so that the metabolite accounts for approximately 20% of sildenafil's pharmacologic results.M